+1 347 708 0418
This report studies the Neurological Biomarkers market, covering market size for segment by type (Proteomics, Genomics, etc.), by application (Diagnostics, Drug Discovery, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck, Quest Diagnostics, Abbott, Roche, Illumina, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Neurological Biomarkers from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Neurological Biomarkers market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Neurological Biomarkers including:
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
Qiagen
Myriad Rbm
Cisbio Bioassays
Athena Diagnostics
Bgi
Wuxi App
Aepodia
Proteome Sciences
Genewiz
Market split by Type, can be divided into:
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market split by Application, can be divided into:
Diagnostics
Drug Discovery
Personalized Medicine
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Neurological Biomarkers Market Overview
1.1 Neurological Biomarkers Definition
1.2 Global Neurological Biomarkers Market Size Status and Outlook (2016-2030)
1.3 Global Neurological Biomarkers Market Size Comparison by Region (2016-2030)
1.4 Global Neurological Biomarkers Market Size Comparison by Type (2016-2030)
1.5 Global Neurological Biomarkers Market Size Comparison by Application (2016-2030)
1.6 Global Neurological Biomarkers Market Size Comparison by Sales Channel (2016-2030)
1.7 Neurological Biomarkers Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Neurological Biomarkers Market Segment Analysis by Player
2.1 Global Neurological Biomarkers Sales and Market Share by Player (2019-2021)
2.2 Global Neurological Biomarkers Revenue and Market Share by Player (2019-2021)
2.3 Global Neurological Biomarkers Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Neurological Biomarkers Market Segment Analysis by Type
3.1 Global Neurological Biomarkers Market by Type
3.1.1 Proteomics
3.1.2 Genomics
3.1.3 Imaging
3.1.4 Bioinformatics
3.1.5 Others
3.2 Global Neurological Biomarkers Sales and Market Share by Type (2016-2021)
3.3 Global Neurological Biomarkers Revenue and Market Share by Type (2016-2021)
3.4 Global Neurological Biomarkers Average Price by Type (2016-2021)
3.5 Leading Players of Neurological Biomarkers by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Neurological Biomarkers Market Segment Analysis by Application
4.1 Global Neurological Biomarkers Market by Application
4.1.1 Diagnostics
4.1.2 Drug Discovery
4.1.3 Personalized Medicine
4.1.4 Others
4.2 Global Neurological Biomarkers Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Neurological Biomarkers by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Neurological Biomarkers Market Segment Analysis by Sales Channel
5.1 Global Neurological Biomarkers Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Neurological Biomarkers Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Neurological Biomarkers Market Segment Analysis by Region
6.1 Global Neurological Biomarkers Market Size and CAGR by Region (2016-2030)
6.2 Global Neurological Biomarkers Sales and Market Share by Region (2016-2021)
6.3 Global Neurological Biomarkers Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Neurological Biomarkers Market Share by Type
6.4.3 North America Neurological Biomarkers Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Neurological Biomarkers Market Share by Type
6.5.3 Europe Neurological Biomarkers Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Neurological Biomarkers Market Share by Type
6.6.3 Asia-Pacific Neurological Biomarkers Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Neurological Biomarkers Market Share by Type
6.7.3 South America Neurological Biomarkers Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Neurological Biomarkers Market Share by Type
6.8.3 Middle East & Africa Neurological Biomarkers Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Neurological Biomarkers Players
7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Quest Diagnostics
7.3 Abbott
7.4 Roche
7.5 Illumina
7.6 Bio-Rad Laboratories
7.7 Qiagen
7.8 Myriad Rbm
7.9 Cisbio Bioassays
7.10 Athena Diagnostics
7.11 Bgi
7.12 Wuxi App
7.13 Aepodia
7.14 Proteome Sciences
7.15 Genewiz
Chapter 8 Upstream and Downstream Analysis of Neurological Biomarkers
8.1 Industrial Chain of Neurological Biomarkers
8.2 Upstream of Neurological Biomarkers
8.3 Downstream of Neurological Biomarkers
Chapter 9 Development Trend of Neurological Biomarkers (2022-2030)
9.1 Global Neurological Biomarkers Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Neurological Biomarkers Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Neurological Biomarkers Example
Figure Global Neurological Biomarkers Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Neurological Biomarkers Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Neurological Biomarkers Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Neurological Biomarkers Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Neurological Biomarkers Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Neurological Biomarkers Sales by Player (2019-2021)
Table Global Neurological Biomarkers Sales Market Share by Player (2019-2021)
Figure Global Neurological Biomarkers Sales Market Share by Player in 2021
Table Global Neurological Biomarkers Revenue (Million $) by Player (2019-2021)
Table Global Neurological Biomarkers Revenue Market Share by Player (2019-2021)
Figure Global Neurological Biomarkers Revenue Market Share by Player in 2021
Table Global Neurological Biomarkers Average Price by Player (2019-2021)
Figure Global Neurological Biomarkers Average Price by Player in 2021
Figure Global Neurological Biomarkers Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global Neurological Biomarkers Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of Proteomics
Figure Global Proteomics Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Genomics
Figure Global Genomics Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Imaging
Figure Global Imaging Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Bioinformatics
Figure Global Bioinformatics Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Neurological Biomarkers Sales by Type (2016-2021)
Table Global Neurological Biomarkers Sales Market Share by Type (2016-2021)
Figure Global Neurological Biomarkers Sales Market Share by Type in 2021
Table Global Neurological Biomarkers Revenue (Million $) by Type (2016-2021)
Table Global Neurological Biomarkers Revenue Market Share by Type (2016-2021)
Figure Global Neurological Biomarkers Revenue Market Share by Type in 2021
Table Global Neurological Biomarkers Average Price by Type (2016-2021)
Figure Global Neurological Biomarkers Average Price by Type in 2021
Table Leading Players of Neurological Biomarkers by Type in 2021
Figure Example of Diagnostics
Figure Global Neurological Biomarkers for Diagnostics Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Drug Discovery
Figure Global Neurological Biomarkers for Drug Discovery Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Personalized Medicine
Figure Global Neurological Biomarkers for Personalized Medicine Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Neurological Biomarkers for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Neurological Biomarkers Sales by Application (2016-2021)
Table Global Neurological Biomarkers Sales Market Share by Application (2016-2021)
Figure Global Neurological Biomarkers Sales Market Share by Application in 2021
Table Leading Consumers of Neurological Biomarkers by Application in 2021
Figure Example of Direct Channel
Figure Global Neurological Biomarkers for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Neurological Biomarkers for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Neurological Biomarkers Revenue by Sales Channel (2016-2021)
Table Global Neurological Biomarkers Revenue Market Share by Sales Channel (2016-2021)
Figure Global Neurological Biomarkers Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2021
Table Global Neurological Biomarkers Market Size and CAGR by Region (2016-2030)
Table Global Neurological Biomarkers Sales by Region (2016-2021)
Table Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
Figure Global Neurological Biomarkers Sales Market Share by Region in 2021
Table Global Neurological Biomarkers Revenue (Million $) by Region (2016-2021)
Table Global Neurological Biomarkers Revenue Market Share by Region (2016-2021)
Figure Global Neurological Biomarkers Revenue Market Share by Region in 2021
Table North America Neurological Biomarkers Sales by Country (2016-2021)
Figure North America Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table North America Neurological Biomarkers Revenue by Country (2016-2021)
Figure North America Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Figure North America Neurological Biomarkers Market Share by Type in 2021
Figure North America Neurological Biomarkers Market Share by Application in 2021
Figure United States Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure United States Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Canada Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Mexico Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Neurological Biomarkers Sales by Country (2016-2021)
Figure Europe Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table Europe Neurological Biomarkers Revenue by Country (2016-2021)
Figure Europe Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Figure Europe Neurological Biomarkers Market Share by Type in 2021
Figure Europe Neurological Biomarkers Market Share by Application in 2021
Figure Germany Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Germany Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure UK Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure France Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure France Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Italy Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Russia Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Spain Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Neurological Biomarkers Sales by Country (2016-2021)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table Asia-Pacific Neurological Biomarkers Revenue by Country (2016-2021)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Neurological Biomarkers Market Share by Type in 2021
Figure Asia-Pacific Neurological Biomarkers Market Share by Application in 2021
Figure China Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure China Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Japan Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Korea Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure India Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure India Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Southeast Asia Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Australia Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Table South America Neurological Biomarkers Sales by Country (2016-2021)
Figure South America Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table South America Neurological Biomarkers Revenue by Country (2016-2021)
Figure South America Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Figure South America Neurological Biomarkers Market Share by Type in 2021
Figure South America Neurological Biomarkers Market Share by Application in 2021
Figure Brazil Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Brazil Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Argentina Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Colombia Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Neurological Biomarkers Sales by Country (2016-2021)
Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2016-2021)
Table Middle East & Africa Neurological Biomarkers Revenue by Country (2016-2021)
Figure Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Neurological Biomarkers Market Share by Type in 2021
Figure Middle East & Africa Neurological Biomarkers Market Share by Application in 2021
Figure UAE Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure UAE Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Neurological Biomarkers Sales and Growth Rate (2016-2021)
Figure South Africa Neurological Biomarkers Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Merck
Table Neurological Biomarkers Introduction of Merck
Table Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share of Merck (2019-2021)
Table Industrial Chain of Neurological Biomarkers
Table Manufacturing Cost Structure of Neurological Biomarkers
Table General Manufacturing Process of Neurological Biomarkers
Table Leading Distributors/Dealers of Neurological Biomarkers
Table Leading Consumers of Neurological Biomarkers
Figure Global Neurological Biomarkers Sales and Growth Rate Forecast (2022-2030)
Figure Global Neurological Biomarkers Revenue and Growth Rate Forecast (2022-2030)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2022-2030)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2022-2030)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2022-2030)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
